Aloxi is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Aloxi is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameAloxi
Authorized genericpalonosetron
Regular genericpalonosetron
What you’d pay
Not soldNo longer sold
Cash priceAsk the pharmacyOften less than Aloxi
Cash priceAsk the pharmacyUsually the lowest
Same as Aloxi?
–
Same medicine
Same active ingredientFillers and dyes can differ

Brand nameNot sold

Aloxi itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.

See the authorized generic →

Authorized genericThe NDC to ask for

The same medicine as Aloxi, without the brand name. Give the pharmacy its NDC to get it.

palonosetron

Sold by
  • Cipla

Given by your care team

This is given by IV at a clinic or hospital, usually before chemotherapy. It isn’t picked up at a pharmacy.

NDC (for your care team)
  • 0.25 mg/5 mLinjection
    • 69097-927-3511-digit: 69097-0927-355 mL per vial

Source: FDA, updated October 30, 2026

What to ask your care team

“Which version of Aloxi do you use: the brand, the authorized generic or a regular generic? What would I pay for each?”

Brand and authorized generic labels

Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).

Aloxi itself isn’t sold anymore, so there’s no current brand label to compare. Here’s the authorized generic’s label.

Authorized genericCipla
See the ingredients

Active: palonosetron hydrochloride 0.25 mg/5 mL

Inactive:

  • Citric acid monohydrate
  • Edetate disodium
  • Mannitol
  • Sodium citrate
  • Water

Regular genericWho makes it

11 companies sell an FDA-rated generic of Aloxi. It’s given by your care team, who choose which one to use.

  • ApotexInjection 0.25 mg/5 mL

    Made by Qilu Pharm Hainan

    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL60505-6193-1
    Carton of 50 mL60505-6193-4

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL60505-6439-1

    Inactive ingredients: mannitol, citric acid monohydrate, sodium citrate, water

    FDA label

  • BluePoint LaboratoriesSolution 0.05 mg/mL · Injection 0.25 mg/5 mL

    Made by Dr. Reddy’s Laboratories and Qilu Pharm Hainan

    How it looks, what’s in it, NDCs

    0.05 mg/mL

    PackageNDC
    Carton of 5 mL68001-355-25

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL68001-708-25

    Inactive ingredients: mannitol, edetate disodium, sodium acetate, water, citric acid monohydrate, sodium citrate form

    FDA label

  • Dr. Reddy’s LaboratoriesSolution 0.05 mg/mL
    How it looks, what’s in it, NDCs

    0.05 mg/mL

    PackageNDC
    Carton of 5 mL55111-694-07
    Carton of 7.5 mL55111-694-19

    Inactive ingredients: mannitol, edetate disodium, sodium acetate, water

    FDA label

  • EugiaSolution 0.25 mg/5 mL

    Product page on eugiaus.com

    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL55150-186-05

    Inactive ingredients: mannitol, edetate disodium, trisodium citrate dihydrate, citric acid monohydrate, hydrochloric acid, sodium hydroxide, water

    FDA label

  • Fresenius KabiSolution 0.25 mg/5 mL

    Product page on fresenius-kabi.com

    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 50 mL63323-673-89

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL63323-673-05

    Inactive ingredients: mannitol, edetate disodium, trisodium citrate dihydrate, anhydrous citric acid, hydrochloric acid, sodium hydroxide

    FDA label

  • Meitheal PharmaceuticalsSolution 0.25 mg/5 mL

    Product page on meithealpharma.com

    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL71288-409-05

    Inactive ingredients: mannitol, edetate disodium, trisodium citrate dihydrate, citric acid monohydrate, hydrochloric acid, sodium hydroxide, water

    FDA label

  • Mylan InstitutionalSolution 0.25 mg/5 mL
    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL67457-317-25

    Inactive ingredients: mannitol, edetate disodium, citric acid monohydrate, sodium citrate form, water, hydrochloric acid, sodium hydroxide

    FDA label

  • NorthStar RxSolution 0.05 mg/mL

    Made by Dr. Reddy’s Laboratories

    Product page on northstarrxllc.com

    How it looks, what’s in it, NDCs

    0.05 mg/mL

    PackageNDC
    Carton of 5 mL16714-834-01

    Inactive ingredients: mannitol, edetate disodium, sodium acetate, water

    FDA label

  • Sagent PharmaceuticalsSolution 0.05 mg/mL
    How it looks, what’s in it, NDCs

    0.05 mg/mL

    PackageNDC
    Carton of 5 mL25021-783-05

    Inactive ingredients: mannitol, edetate disodium, citric acid monohydrate, water, sodium hydroxide, hydrochloric acid, trisodium citrate dihydrate

    FDA label

  • SandozSolution 0.25 mg/5 mL
    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL0781-3312-75
    Carton of 50 mL0781-3312-95

    Inactive ingredients: mannitol, edetate disodium, trisodium citrate dihydrate, citric acid monohydrate, hydrochloric acid, sodium hydroxide, water

    FDA label

  • Teva Parenteral MedicinesSolution 0.25 mg/5 mL

    Being phased out; sold until December 2026

    How it looks, what’s in it, NDCs

    0.25 mg/5 mL

    PackageNDC
    Carton of 5 mL0703-4094-01

    Inactive ingredients: mannitol, edetate disodium, trisodium citrate dihydrate, citric acid monohydrate, water, hydrochloric acid, sodium hydroxide

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

What the FDA label says

Palonosetron Hydrochloride Injection is a serotonin-3 (5-HT3) receptor antagonist indicated in adults for:

  • Moderately emetogenic cancer chemotherapy - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses
  • Highly emetogenic cancer chemotherapy - prevention of acute nausea and vomiting associated with initial and repeat courses
  • Prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery. Efficacy beyond 24 hours has not been demonstrated

Palonosetron Hydrochloride Injection is indicated in pediatric patients aged 1 month to less than 17 years for:

  • Prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy

Source: the FDA label for palonosetron hydrochloride (Cipla USA Inc.), January 13, 2022. Full label on DailyMed 

Good to know